APH
55
5
QCOM
53
2
WBA
66
2
PGR
49
10
TDC
60
3
ETN
65
-2
NUE
41
-2
R
60
5
UA
39
-6
CCL
54
4
USB
55
2
OMC
37
2
ALL
38
3
CSCO
66
6
EXC
64
3
HD
40
2
PEG
57
4
TROW
45
8
CLX
68
3
DAL
64
2
APH
55
5
QCOM
53
2
WBA
66
2
PGR
49
10
TDC
60
3
ETN
65
-2
NUE
41
-2
R
60
5
UA
39
-6
CCL
54
4
USB
55
2
OMC
37
2
ALL
38
3
CSCO
66
6
EXC
64
3
HD
40
2
PEG
57
4
TROW
45
8
CLX
68
3
DAL
64
2
Financhill
Back

Enphase Energy Vs. Blueprint Medicines Industry Stock Comparison

Sell
28

ENPH
Enphase Energy

Last Price:
$65.43
Seasonality Move:
21.58%
Sell
40

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Sell
28
Enphase Energy (ENPH) is a Sell

Is Enphase Energy a Buy, Sell or Hold?

  • The current Enphase Energy [ENPH] share price is $65.45. The Score for ENPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ENPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ENPH Stock Price Chart

What is Enphase Energy's stock price today?

  • The Enphase Energy share price today is $65.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENPH is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $102.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

ENPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 39.3 Sell
Chaikin Money Flow: -2684912 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.48 - 74.08) Sell
Bollinger Bands (100): (68.31 - 109.33) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 63.82 Buy
Chaikin Money Flow: -913925 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.06 - 96.6) Buy
Bollinger Bands (100): (86.99 - 95.95) Buy

ENPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.64 Sell
20-day SMA: 70.62 Sell
50-day SMA: 70.83 Sell
200-day SMA: 101.37 Sell
8-day EMA: 68.64 Sell
20-day EMA: 70.21 Sell
50-day EMA: 74.79 Sell
200-day EMA: 97.13 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 91.76 Buy
50-day SMA: 93.83 Buy
200-day SMA: 96.87 Buy
8-day EMA: 94.89 Buy
20-day EMA: 92.92 Buy
50-day EMA: 92.72 Buy
200-day EMA: 91.71 Buy

Enphase Energy Earnings Growth & ENPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.57 per share, and an increase next year of $1.01 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

Enphase Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):